IMPAX LABORATORIES INC Business Finance Contracts & Agreements
13 Contracts & Agreements
- Credit Agreements (2 contracts)
- Exchange Agreements (2)
- Indenture Agreements (3)
- Loan Agreements (1)
- Release Agreements (3)
- Stock Agreements (2)
- Second Supplemental Indenture (Filed With SEC on May 7, 2018)
- Stock and Asset Purchase Agreement, dated as of December 19, 2017, by and between the Company and Bora Pharmaceuticals Co., Ltd (Filed With SEC on March 1, 2018)
- Supplemental Indenture, dated November 6, 2017, by and between Impax Laboratories, Inc. and Wilmington Trust, National Association (Filed With SEC on November 7, 2017)
- IMPAX LABORATORIES, INC. STOCK OPTION AGREEMENT (Filed With SEC on May 10, 2017)
- AMENDMENT NO. 1 TO CREDIT AGREEMENT (Filed With SEC on May 10, 2017)
- General Release and Waiver (Filed With SEC on March 1, 2017)
- IMPAX LABORATORIES, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of June 30, 2015 2.00% Convertible Senior Notes due 2022 TABLE OF CONTENTS (Filed With SEC on June 30, 2015)
- Exhibit 10.2[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.Confidential treatment has been requested... (Filed With SEC on May 3, 2013)
- [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.Confidential treatment has been requested with respect... (Filed With SEC on February 26, 2013)
- SECOND AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on January 10, 2013)
- General Release and Waiver (Filed With SEC on July 18, 2012)
- SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on March 12, 2009)
- Exhibit 10.1 CONSULTING/SEPARATION AGREEMENT AND FULL MUTUAL RELEASE (Filed With SEC on August 18, 2006)
